Collin Shaw, Author at Buhlmann Diagnostics Corp

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

BÜHLMANN fCAL® ELISA: Kristensen, V., A. Roseth, et al. Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis. Gastroenterology Research and Practice; Volume 2017 (2017), Article ID 2098293, 5 pages. DOI: 10.1155/2017/2098293. Highlights from this Publication “Conclusions. Fecal calprotectin <250 μg/g after medical treatment for active ulcerative colitis is a reliable marker of endoscopic

Do Not Forget About Pre-Analytics in Faecal Calprotectin Measurement!

BÜHLMANN fCAL® turbo and CALEX® Cap: Oyaert, M., Van den Bremt, S. et al. Do not forget about pre-analytics in faecal calprotectin measurement! Clinica Chimica Acta. 2017 Oct; 473:124-126. doi:10.1016/j.cca.2017.08.025. PMID: 28847684 . Highlights from this Publication This study found an optimal stability of fecal calprotectin when sampled with CALEX® extraction buffer and stored at 2-8 °C for 7 days. Furthermore, the

BUHLMANN LabSense News: Summer 2017 Edition

BUHLMANN Diagnostics Corp is proud to release the fourth edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. You won't want to

Webinar: The Application of Data-Driven Approaches to Flow Cytometric Analysis of Basophil Activation Testing

Using Flow CAST® for the Development of a High Throughput, Objective Approach to Basophil Activation Image credit: Sarita U. Patil et al. (full citation below) DOWNLOAD eBOOK Webinar Recording Abstract We have developed and implemented a new data-driven, programmatic approach to the analysis of flow cytometry data from basophil activation testing. While conventional data analysis of flow

CALEX® Cap Highlights

CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 98839 CALEX® Cap Extraction Video Rapid, Clean, Consistent and Safe Sample Preparation The CALEX®Cap extraction device is designed to fulfill the requirements and need in the market for convenient and safe stool extraction. BÜHLMANN has strived to provide the best stool extraction option for calprotectin testing and

Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay

Flow CAST®Kinase Inhibition Assay Citation: Wise S. et al. Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay. SLAS 2014. 3rd Annual Conference & Exhibition. January 18-22, 2014. San Diego, CA Highlights from this Poster "Monitoring basophil activation in whole blood via flow cytometry is an accurate method for measuring a pharmacodynamic response

Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests

Flow CAST® Assay: Sarita U. Patil et al. Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests Cytometry B Clin Cytom. 2017 Jun 15. doi: 10.1002/cyto.b.21537. PMID: 28618453. Highlights from this Publication Peanut Flow CAST® assay has been the core standardize assay for the first evaluation of on an automated analysis of Basophil activation test results. Flow CAST® results

Diagnostic Accuracy of Fecal Calprotectin in Assessing the Severity of Inflammatory Bowel Disease: From Laboratory to Clinic

BÜHLMANN fCAL® ELISA: S. Moein, D. Quujeq et al. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. Caspian J Intern Med 2017; 8(3):178-182 DOI: 10.22088/cjim.8.3.178. Highlights from this Publication “ The current study also suggested 78.4 µg/g as the cut-off level for FC by 100% sensitivity and

Announcing Enhancement to Quantum Blue^® fCAL (Calprotectin) High Range Assay

Quantum Blue® fCAL High Range Enhancements BUHLMANN is happy to introduce a revised and enhanced version of our Quantum Blue® fCAL high range test (LF-CHR25) to the market. The changes result in several beneficial features that not only further simplify the procedure but also improve performance characteristics. Enhancements and Benefits: Sample dilution NOW in extraction

Come Visit BUHLMANN at AMLI 2017- Booth #13

AMLI 2017 BUHLMANN Diagnostics Corp Booth: #13 August 13 - 16, 2017 Renaissance Stapleton Hotel | Denver, C0 LEARN MORE Click & Contact our AMLI 2017BUHLMANN Team Connect with our team ahead of time, learn more about the BÜHLMANN's Products and Solutions or schedule a meeting! Jennifer Stuart, Technical Sales Specialist JENNIFER STUART Technical Sales Specialist jls@buhlmannlabs.com

Author: Collin Shaw

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

Do Not Forget About Pre-Analytics in Faecal Calprotectin Measurement!

BUHLMANN LabSense News: Summer 2017 Edition

Webinar: The Application of Data-Driven Approaches to Flow Cytometric Analysis of Basophil Activation Testing

CALEX® Cap Highlights

Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay

Diagnostic Accuracy of Fecal Calprotectin in Assessing the Severity of Inflammatory Bowel Disease: From Laboratory to Clinic

Announcing Enhancement to Quantum Blue^® fCAL (Calprotectin) High Range Assay

Come Visit BUHLMANN at AMLI 2017- Booth #13

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US